Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

120 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Habitat escalated adaptive therapy (HEAT): a phase 2 trial utilizing radiomic habitat-directed and genomic-adjusted radiation dose (GARD) optimization for high-grade soft tissue sarcoma.
Naghavi AO, Bryant JM, Kim Y, Weygand J, Redler G, Sim AJ, Miller J, Coucoules K, Michael LT, Gloria WE, Yang G, Rosenberg SA, Ahmed K, Bui MM, Henderson-Jackson EB, Lee A, Lee CD, Gonzalez RJ, Feygelman V, Eschrich SA, Scott JG, Torres-Roca J, Latifi K, Parikh N, Costello J. Naghavi AO, et al. Among authors: eschrich sa. BMC Cancer. 2024 Apr 9;24(1):437. doi: 10.1186/s12885-024-12151-7. BMC Cancer. 2024. PMID: 38594603 Free PMC article. Clinical Trial.
A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study.
Scott JG, Berglund A, Schell MJ, Mihaylov I, Fulp WJ, Yue B, Welsh E, Caudell JJ, Ahmed K, Strom TS, Mellon E, Venkat P, Johnstone P, Foekens J, Lee J, Moros E, Dalton WS, Eschrich SA, McLeod H, Harrison LB, Torres-Roca JF. Scott JG, et al. Among authors: eschrich sa. Lancet Oncol. 2017 Feb;18(2):202-211. doi: 10.1016/S1470-2045(16)30648-9. Epub 2016 Dec 18. Lancet Oncol. 2017. PMID: 27993569 Free PMC article.
Radiosensitivity of Lung Metastases by Primary Histology and Implications for Stereotactic Body Radiation Therapy Using the Genomically Adjusted Radiation Dose.
Ahmed KA, Scott JG, Arrington JA, Naghavi AO, Grass GD, Perez BA, Caudell JJ, Berglund AE, Welsh EA, Eschrich SA, Dilling TJ, Torres-Roca JF. Ahmed KA, et al. Among authors: eschrich sa. J Thorac Oncol. 2018 Aug;13(8):1121-1127. doi: 10.1016/j.jtho.2018.04.027. Epub 2018 May 5. J Thorac Oncol. 2018. PMID: 29733909 Free PMC article.
Utilizing the genomically adjusted radiation dose (GARD) to personalize adjuvant radiotherapy in triple negative breast cancer management.
Ahmed KA, Liveringhouse CL, Mills MN, Figura NB, Grass GD, Washington IR, Harris EE, Czerniecki BJ, Blumencranz PW, Eschrich SA, Scott JG, Diaz R, Torres-Roca JF. Ahmed KA, et al. Among authors: eschrich sa. EBioMedicine. 2019 Sep;47:163-169. doi: 10.1016/j.ebiom.2019.08.019. Epub 2019 Aug 12. EBioMedicine. 2019. PMID: 31416721 Free PMC article.
Personalizing Radiotherapy Prescription Dose Using Genomic Markers of Radiosensitivity and Normal Tissue Toxicity in NSCLC.
Scott JG, Sedor G, Scarborough JA, Kattan MW, Peacock J, Grass GD, Mellon EA, Thapa R, Schell M, Waller A, Poppen S, Andl G, Teer JK, Eschrich SA, Dilling TJ, Dalton WS, Harrison LB, Fox T, Torres-Roca JF. Scott JG, et al. Among authors: eschrich sa. J Thorac Oncol. 2021 Mar;16(3):428-438. doi: 10.1016/j.jtho.2020.11.008. Epub 2020 Dec 8. J Thorac Oncol. 2021. PMID: 33301984 Free PMC article.
Differences Between Colon Cancer Primaries and Metastases Using a Molecular Assay for Tumor Radiation Sensitivity Suggest Implications for Potential Oligometastatic SBRT Patient Selection.
Ahmed KA, Fulp WJ, Berglund AE, Hoffe SE, Dilling TJ, Eschrich SA, Shridhar R, Torres-Roca JF. Ahmed KA, et al. Among authors: eschrich sa. Int J Radiat Oncol Biol Phys. 2015 Jul 15;92(4):837-42. doi: 10.1016/j.ijrobp.2015.01.036. Epub 2015 Mar 30. Int J Radiat Oncol Biol Phys. 2015. PMID: 25838188 Free PMC article.
120 results